SRSomayeh Reiisi

Somayeh Reiisi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Somayeh Reiisi has a total of 120 co-authors. Here are the top co-authors by number of shared publications:

  • Seyed Omar Ebrahimi

    Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran

    12 shared publications
  • Shahrzad Shahbazi

    Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan

    11 shared publications
  • Razieh Heidari

    Department of Medical Biotechnology School of Advanced Technologies, Shahrekord University of Medical Sciences Shahrekord Iran

    9 shared publications
  • Kambiz Ahmadi

    6 shared publications
  • Forough Taheri

    Department of Genetics, Sharekord Branch Islamic Azad University Sharekord

    4 shared publications
  • Sadegh Shirian

    Department of Pathobiology, Faculty of Veterinary Medicine Shahrekord University Shahrekord Iran

    4 shared publications

Latest Publications

  • Anticancer Effect of Co(III) Complex of a Thiourea Derivative on Inhibiting Breast Cancer Cell Proliferation Using In Silico and In Vitro Evaluations

    by Fatemeh Khodabakhshi, Somayeh Reiisi, Sajjad Rakhshani, Mehran Feizi‐Dehnayebi

    Breast cancer remains a leading cause of cancer‐related mortality worldwide, highlighting the need for novel therapeutic agents with improved selectivity and multifunctional activity. In this study, a novel cobalt(III) complex, Co(L2) 3 [L2 = 2‐chloro‐N‐(2,2‐dimethyloxazolidine‐3‐carbonothioyl)benzamide], was synthesized and evaluated using integrated in vitro and in silico approaches. The ligand and complex were characterized by FT‐IR, UV–Vis, and 1 H NMR spectroscopy. The antiproliferative activity was assessed in MCF‐7, MDA‐MB‐231, and HUVEC cells using the MTT assay. IC 50 values were 176.95 ± 2.84 µg/mL for MCF‐7, 187.01 ± 0.47 µg/mL for MDA‐MB‐231, and 354.96 ± 1.14 µg/mL for HUVEC cells, corresponding to selectivity indices of 2.01 and 1.90, respectively. Co(L2) 3 reduced colony formation and cell migration and increased glutathione reductase activity. Gene expression analysis showed upregulation of CASP3 and CASP9 and downregulation of BCL2, CDC25A, MMP2, and MMP9, indicating modulation of apoptosis‐, cell‐cycle‐, and metastasis‐related responses. Molecular docking predicted favorable interactions with CDC25A, MMP‐2, and MMP‐9. Collectively, these findings indicate that Co(L2) 3 exhibits preferential in vitro anticancer activity against the tested breast cancer cell lines and warrant further investigation as a potential multifunctional anticancer agent.

  • Salicylic acid attenuates paclitaxel-induced toxicity by modulating interleukin expression: an in vivo study

    by Farah Al-Najar, Shahrzad Shahbazi, Somayeh Reiisi, Behnaz Saffar, Elham Moghtadaei Khorasgani

    Paclitaxel (PAX) is an effective chemotherapeutic agent for treating various cancers but is associated with side effects such as hepatotoxicity, neurotoxicity, and myelosuppression. To mitigate these toxicities, adjunct therapies like salicylic acid (SA), a plant-derived compound with anti-inflammatory, antioxidant, and cytoprotective properties, have been explored. This study investigates SA's potential to counteract PAX's cytotoxic effects, focusing on hepatic tissue. Thirty-five BALB/cJ mice were treated with PAX and SA, either individually or in combination (low and high doses), for 14 days. Post-treatment, biochemical and histological analyses were performed. ELISA assays measured serum levels of inflammatory markers IL-1β, IL-6, and TNF-α, while caspase-3/7 activity was evaluated to assess apoptosis. qPCR assessed gene expression related to apoptosis (CASP1, CASP3, Bcl-2). Results showed that PAX significantly increased serum levels of inflammatory markers, which were reduced by SA treatment. PAX also elevated caspase-3/7 activity, but co-treatment with SA suppressed this effect. Histological analysis revealed that low-dose SA alleviated PAX-induced necrosis and inflammation in the liver, kidney, and spleen. Moreover, PAX alone significantly upregulated CASP1 and CASP3 expression, while co-treatment with SA significantly downregulated these genes. These findings highlight the protective role of SA in reducing PAX-induced toxicity, particularly in hepatic tissues, suggesting that SA could be a potential adjunct therapy for minimizing chemotherapy-related side effects.

  • Synergistic and Molecular Docking Evaluation of Doxycycline Combined With Tannic, Salicylic, and Boric Acids Against Staphylococcus aureus

    by Karrar Al‐Aklah, Somayeh Reiisi, Gharsrhasb Rigi, Razieh Heidari, Mehran Feizi‐Dehnayebi

    Staphylococcus aureus is an important human pathogen with a high potential for antibiotic resistance and zoonotic transmission. Doxycycline is widely used in human and poultry infections, but its extensive application has accelerated the emergence of resistant strains. This study evaluated the potential of tannic acid, salicylic acid, and boric acid as adjuvants to doxycycline against S. aureus isolated from frozen chicken meat. Isolates were identified using selective culture media and biochemical tests. Antimicrobial activity was determined by broth microdilution assays to measure minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values. Synergistic interactions were assessed using the fractional inhibitory concentration index (FICI), while antibiofilm activity was also investigated. In addition, molecular docking analysis was performed using the target protein structure (PDB ID: 4URO). Doxycycline showed a MIC value of 0.5 μg/mL, whereas tannic acid, salicylic acid, and boric acid exhibited MIC values of 500, 1000, and 2000 μg/mL, respectively. Combination treatments reduced the MIC of doxycycline to 0.125 μg/mL with tannic acid and 0.25 μg/mL with salicylic acid, confirming synergistic effects, while boric acid showed no synergism. MBC and biofilm inhibition assays further supported the enhanced antibacterial activity of doxycycline combined with tannic acid or salicylic acid. Molecular docking results were consistent with the biological findings, showing the strongest binding affinity for doxycycline (−6.92 kcal/mol), followed by tannic acid (−5.61 kcal/mol) and salicylic acid (−5.49 kcal/mol), whereas boric acid showed weak binding (−3.22 kcal/mol). Overall, tannic acid and salicylic acid significantly enhanced the antimicrobial and antibiofilm effects of doxycycline against S. aureus , suggesting their potential as natural adjuvants for combating antibiotic resistance.


  • Top Cited Papers
    Open Access

    Imidazole-based chemosensor for the detection of Ag+ ions: Antimicrobial activity, DFT insight, and molecular docking modeling

    by Mohammad Goodarzi, Ghodsi Mohammadi Ziarani, Zahra Panahande, Somayeh Reiisi, Mehran Feizi-Dehnayebi


  • A PVA /chitosan/gelatin scaffold incorporating salicylic acid‐loaded TiO ₂ nanoparticles enhances collagen I expression and accelerates cutaneous wound repair in mice

    by Parvin Safaiefar, Somayeh Reiisi, Mehdi Haghi, Sadegh Shirian

    Wound healing is a complex biological process requiring coordinated cellular and molecular responses, motivating the development of bioactive scaffolds capable of modulating the wound microenvironment. In this study, a nanocomposite scaffold composed of chitosan, polyvinyl alcohol (PVA), and gelatin incorporating salicylic acid‐loaded titanium dioxide nanoparticles (TiO₂ NPs) was fabricated and evaluated for wound‐healing applications. TiO₂ nanoparticles synthesized via a co‐precipitation method exhibited nanoscale dimensions, high crystallinity, a negative surface charge (−19.4 mV), and a drug‐loading efficiency exceeding 90%. The scaffold showed good structural integrity under physiological conditions, excellent hemocompatibility (p < 0.05), while maintaining high cell viability. In a murine excisional wound model, the nanocomposite‐treated group achieved 85% wound closure by day 10, compared with 30% in untreated wounds and 50% in the drug‐free scaffold group ( p < 0.05), along with improved epidermal regeneration. Overall, these results indicate that controlled delivery of salicylic acid from a TiO₂‐containing polymeric scaffold supports fibroblast activity, collagen‐related responses, and wound closure, providing a rational basis for further optimization of multifunctional wound dressings.


  • Synergistic anti-microbial and anti-biofilm effects of tannic acid and tetracycline co- encapsulated in mesoporous silica nanoparticles against Staphylococcus aureus

    by Qays Qandeel, Shahrzad Shahbazi, Somayeh Reiisi, Garshasb Rigi

    This study aimed to develop a mesoporous silica nanoparticle (MSN)-based dual-drug delivery system co-encapsulating tannic acid (TA) and tetracycline (TC) to enhance antibacterial and antibiofilm efficacy and to explore its potential involvement in efflux pump - related mechanisms. MSNs were synthesized and loaded with TA and TC individually (MSN@TA, MSN@TC) and in combination (MSN@TA/TC). Physicochemical properties, including morphology, size, surface charge, and drug loading, were characterized. Antibacterial activity was assessed using MIC and MBC assays. Biofilm inhibition was evaluated by crystal violet staining, and NorA gene expression was measured by qPCR. MSNs were spherical with a size of 100-150 nm and a zeta potential of -45.8 mV. The co-loaded MSN@TA/TC showed superior antibacterial activity (MIC: 31.25 µg/mL; MBC: 62.5 µg/mL) compared to single-drug systems. Biofilm formation was reduced by 35-95% in a dose-dependent manner, with the highest inhibition observed for MSN@TA/TC. Moreover, NorA expression was downregulated by 4.5-fold following treatment. Co-encapsulation of TA and TC in MSNs significantly enhanced antibacterial and antibiofilm effects against S. aureus, likely through modulation of efflux pump-associated resistance. This nanocarrier system shows promise for improving antibiotic efficacy in biofilm-associated infections.


  • Open Access

    Novel p53-related lncRNAs as immune-associated biomarkers in colorectal cancer

    by Zahra Sadat Tabatabaei Jafari, Shahrzad Shahbazi, Somayeh Reiisi, Kambiz Ahmadi, Mohammad Mahdevar

    Background: The p53 signaling pathway plays a critical role in colorectal cancer (CRC) development and progression. However, the contribution of p53-associated long noncoding RNAs (lncRNAs) to tumor biology and their potential clinical relevance remain insufficiently understood. This study aimed to identify clinically relevant p53-related lncRNAs and evaluate their diagnostic and immune-associated significance in CRC. Methods: RNA sequencing and clinical data from 483 CRC and 41 normal tissues in TCGA-COAD, along with independent GEO datasets (GSE39582 and GSE128449), were analyzed to identify differentially expressed genes and noncoding RNAs. Prognostic relevance was assessed using Cox regression analysis. Associations with tumor immune infiltration were evaluated using computational immune estimation methods. A regulatory interaction network was constructed to identify key lncRNAs. Expression levels of selected candidates were validated by quantitative real-time PCR in 25 paired CRC and adjacent normal tissues. Results: Seventy-four p53-associated genes were consistently dysregulated across datasets. Network integration highlighted two lncRNAs, MIR23AHG and MIRLET7BHG, as central regulatory candidates. Both were significantly upregulated in CRC tissues and demonstrated moderate-to-good diagnostic performance (AUC = 0.80 and 0.77, respectively). Survival analysis identified CD82, CDKN2A, and INHBB as risk-associated genes. The identified p53-related signature showed significant correlations with immune cell infiltration, particularly CD4⁺ T cells, dendritic cells, and B cells. qPCR validation confirmed marked overexpression of MIR23AHG and MIRLET7BHG in clinical CRC samples. Conclusion: MIR23AHG and MIRLET7BHG are novel p53-associated lncRNAs that show promising diagnostic potential and immune-related relevance in CRC. While not proposed as standalone clinical markers, these lncRNAs may serve as complementary molecular biomarkers and warrant further functional and prospective clinical validation.

  • Synergistic anticancer effects of tamoxifen in combination with fisetin and chrysin on breast cancer cells: insights into viability, migration, and apoptosis

    by Negar Karami-Dehkordi, Somayeh Reiisi, Mehran Feizi-Dehnayebi

    Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide. Tamoxifen (TX) is widely used for the treatment of estrogen receptor–positive (ER⁺) breast cancer; however, the development of drug resistance limits its long-term therapeutic effectiveness. Fisetin (Fis) and chrysin (Chry) are naturally occurring flavonoids that have demonstrated anticancer properties, including inhibition of cell proliferation and migration and induction of apoptosis. In this study, we evaluated the anticancer effects of Fis and Chry, individually and in combination with TX, in ER⁺ MCF-7 and triple-negative MDA-MB-231 breast cancer cell lines. Cells were treated with varying concentrations of Fis or Chry alone or in combination with TX. Cell viability was assessed using the MTT assay, while migratory and clonogenic capacities were evaluated by wound-healing and colony formation assays, respectively. Apoptosis was analyzed by flow cytometry, and the expression of invasion-related genes (MMP2 and MMP9) was quantified using real-time PCR. The results showed that Fis, Chry, and TX individually reduced cell viability, migration, and colony formation in both cell lines. Notably, combination treatments exerted significantly stronger cytotoxic and pro-apoptotic effects compared to single-agent treatments. Combination index (CI) analysis revealed CI values below 1, indicating a synergistic interaction between TX and the flavonoids. Furthermore, co-treatment markedly downregulated MMP2 and MMP9 expression. Collectively, these findings demonstrate that fisetin and chrysin enhance the anticancer efficacy of tamoxifen through synergistic mechanisms in breast cancer cells.


  • Open Access

    Flavonoids and miRNA Modulation: A Novel Approach to Managing Cancer, Diabetes, Depression, and Neurological Disorders

    by Mohadese Mahdie, Sedigheh Momenzadeh, Somayeh Reiisi, Razieh Heidari

    MicroRNAs (miRNAs) regulate gene expression post‐transcriptionally and play essential roles in various cellular processes. Disruption of their normal expression contributes to the pathogenesis of numerous diseases, including cancer, diabetes, depression, and neurological disorders. Consequently, restoring or inhibiting miRNA function has become a major focus of research, utilizing advanced technologies. Despite their potential, the clinical application of these technologies remains limited due to challenges related to delivery, specificity, cost, and safety. In contrast, growing evidence suggests that natural compounds—particularly flavonoids, a class of polyphenolic compounds abundant in plant‐based foods such as fruits, vegetables, tea, and whole grains—can beneficially modulate miRNA expression. Studies across various disease models have demonstrated that flavonoids influence disease‐related pathways through miRNA regulation, showing promising results in reducing disease complications, especially in preclinical mouse models. Therefore, diets rich in flavonoids are not only beneficial for disease prevention but also hold potential therapeutic value through the targeted modulation of miRNAs. The effectiveness of flavonoids across a wide spectrum of chronic diseases introduces a novel class of miRNA modulators with significant potential for clinical application. This review comprehensively examines recent studies on the use of various flavonoids in cellular models, animal models, and human tissue samples related to cancer, diabetes, depression, and neurological disorders. It further explores the molecular mechanisms through which flavonoids regulate miRNA expression, including transcriptional control, epigenetic modifications, and modulation of signaling pathways. Additionally, the review discusses the therapeutic opportunities and challenges associated with flavonoid use and proposes potential strategies to overcome these limitations.

  • Enhancing wound healing: incorporating carotenoid pigments from Kocuria Sp. bacteria in alginate/Chitosan/PVA dressing

    by Morteza Karimian Dorhoni, Norolhoda Khalighi, Somayeh Reiisi, Razieh Heidari, Sadegh Shirian

    Chronic wounds represent a significant clinical challenge, necessitating the development of multifunctional dressings with bioactive compounds to accelerate healing. Carotenoids—natural pigments with potent antioxidant and anti-inflammatory properties—are emerging as promising agents for tissue repair. This study explores the therapeutic potential of carotenoid pigments biosynthesized by Kocuria sp. and their integration into a chitosan/alginate/polyvinyl alcohol (Cs/Alg/PVA) nanocomposite for wound healing applications. Carotenoids were extracted and optimized under varying conditions of temperature, salinity, pH, and culture media. The pigments were incorporated into a Cs/Alg/PVA matrix and characterized using Fourier transform infrared spectroscopy, scanning electron microscopy, differential scanning calorimetry (DSC), and in vitro release studies. Antioxidant capacity was evaluated via DPPH assay, and anti-inflammatory properties were assessed using hemolysis assays. Cell viability and proliferation were analyzed on L929 and human dermal fibroblast cells using MTT assay. In vivo wound healing efficacy was evaluated in a murine excisional wound model with histological and morphometric analyses. The carotenoid-enriched composite exhibited strong antioxidant activity, significant anti-hemolytic effects, and enhanced biocompatibility with fibroblasts. Release kinetics revealed sustained and pH-responsive delivery of carotenoids. In vivo , the composite significantly accelerated wound contraction and epithelialization compared to controls, with histopathological analysis confirming increased fibroblast presence, collagen deposition, and reduced inflammation. This study highlights the therapeutic potential of microbial carotenoids embedded in Cs/Alg/PVA dressings as a biocompatible, antioxidant-rich platform for enhanced wound healing. The approach offers a sustainable, natural alternative to synthetic additives in wound care biomaterials.